BSEMitsu Chem Plast LtdMediumNeutral
Announced Thu, 8 May · 21:19 IST

Investor Presentation for Q4 FY2024-25 of the Company.

Analyst Day Multiyear TargetsMgmt Guided Margin PressureCfo Debt Reduction RoadmapInvestor Communications View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mitsu Chem Plast filed its Q4 FY25 investor presentation, reporting total income of ₹90.51 Cr in Q4 (up ~9.6% YoY) with net profit of ₹3.54 Cr, a 25% jump from ₹2.83 Cr in Q4 FY24. Full-year FY25 revenue grew to ₹332.28 Cr (from ₹311.25 Cr), but EBITDA fell to ₹23.28 Cr (from ₹25.67 Cr) and PAT declined to ₹7.25 Cr (from ₹8.86 Cr), with net profit margin compressing to 2.18%. The company highlighted a multi-year target to reach ₹1,000 Cr revenue by FY28 (3x FY24 levels), driven by four pillars including its new hospital furniture brand Furnastra, packaging growth, operational excellence, and data-driven marketing. Exports surged 144% YoY in FY25, supported by participation in global trade fairs across UAE, Germany, Brazil, and Malaysia. The company also outlined ESG targets including 20% reduction in carbon and energy intensity and 15% reduction in water consumption.

Likely market impact

The presentation shows Q4 recovery in profitability but full-year margin compression remains a concern for shareholders, as costs have grown faster than revenue. The ₹1,000 Cr FY28 revenue target and strong export growth offer a positive growth narrative, though execution and margin recovery will be key drivers for stock price performance.